NLA Comments on Proposed Retirement for HEDIS 2015 with Respect to Cholesterol Management for Patients with CVD Conditions and Diabetes

The National Committee for Quality Assurance (NCQA) has proposed retiring the use of LDL-C treatment targets in response to the new ACC/AHA Task Force on Practice Guidelines. The NCQA has stated that no studies focus on treatment or titration to a specific LDL-C goal in adults with clinical atherosclerotic cardiovascular disease (ASCVD). The NLA is strongly opposed to this and submitted a statement against retiring such an important measurement.

Please click here to read the full statement.